Argenx (ARGX)
(Delayed Data from NSDQ)
$536.70 USD
+9.45 (1.79%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $536.78 +0.08 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$536.70 USD
+9.45 (1.79%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $536.78 +0.08 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth D Momentum F VGM
Zacks News
argenx (ARGX): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
argenx (ARGX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
argenx Up on Positive Data from Pivotal Efgartigimod Study
by Zacks Equity Research
argenx's (ARGX) lead pipeline candidate, efgartigimod, meets primary endpoint in a pivotal study evaluating it in myasthenia gravis. A BLA is likely to be filed by the end of 2020.
Biotech Stock Roundup: REGN's Stake Buyback, INO, NVAX's Coronavirus Updates & More
by Zacks Equity Research
The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.
Halozyme (HALO) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Halozyme (HALO) reports wider-than-expected Q1 loss. Shares down.
Top Ranked Momentum Stocks to Buy for February 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 27th
Why Earnings Season Could Be Great for argenx (ARGX)?
by Zacks Equity Research
argenx (ARGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's Why Momentum Investors Will Love ARGENX SE-ADR (ARGX)
by Zacks Equity Research
Does ARGENX SE-ADR (ARGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Company News For Dec 12, 2017
by Zacks Equity Research
Companies in the news are: KMG,ARGX,BPMC,BLUE
Company News for June 13, 2017
by Zacks Equity Research
Companies in the News are: WCST,CACI,TWX,ARGX